To Access the Effects of Mucositis in Adults With Dental Implants

NCT01072201 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-10-05

Study results available
· View outcomes & findings →

Summary

Clinical research for the treatment of mucositis subjects who have dental implants for a minimum of one-year.

Conditions

Interventions

DRUG

Triclosan and Fluoride

Brush twice daily

DRUG

Fluoride

Brush twice daily

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Principal Investigators

  • Per Ramberg, DDS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01072201 on ClinicalTrials.gov